Source disclosure: February 10, 2026
Cyfuse Biomedical K.K. [4892.T]
TOKYO, Feb 10 (Pulse News Wire) – Cyfuse Biomedical K.K. (4892.T) announced today that the issuance details of its 25th round of stock options (stock options) to employees have been finalized based on the resolution made at the board meeting held on January 22, 2026.
In the latest issuance, a total of 200 stock options will be granted to 12 company employees. The stock options are tied to ordinary shares totaling 20,000 shares.
This issuance marks another step in Cyfuse Biomedical's ongoing efforts to incentivize and retain key talent through equity-based compensation programs.
AI-translated content. 🟢 Confidence: High See terms • Original filing
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.